J9VF33 AF NFT

ABC multidrug transporter MDR1

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiaihojhomyecuekct27idndwvximts4mptdl52ao4676l3kknfj3e/metadata.json
IPFS of structure file: 
bafybeigbqpcsnzvuitm6n4ocuzp7qswh6uswgixy7pqqcycjbp3vs6r53e/AF-J9VF33-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xE4E7B2ca7D406E6bc95fEB877da5B1E0D0e67Ffc
First NFT owner address (bech32): 
genesis1unnm9jnagphxhj2lawrhmfd3urgwvllueqnwp4
Current NFT ID #227916 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
227916
Accession (UniProt):
J9VF33
Name::
ABC multidrug transporter MDR1
Experimental Method:
Predicted structure
Sequence source:
CRYPTOCOCCUS NEOFORMANS VAR. GRUBII SEROTYPE A (STRAIN H99 / ATCC 208821 / CBS 10515 / FGSC 9487)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT J9VF33 research and analysis (ICN3D with VR)

FASTA sequences

>sp|J9VF33|MDR1_CRYNH ABC multidrug transporter MDR1 OS=Cryptococcus neoformans var. grubii serotype A (strain H99 / ATCC 208821 / CBS 10515 / FGSC 9487) OX=235443 GN=MDR1 PE=1 SV=1 MSASPGLTAAAAGPDHLQARRDEKVIDSEKDALAHDAHAVNSGIPYPTATAPNVGAPTVPISVGRVSSAAEGKISRSSIAASSDTLRNSPLEKPISNAFSKSHPYKKSKFDFLKSRKKKEEEERKNKEKEKEASVLPPVSFFALFRFAAPLEIIAMVLGLVLAVAAGSCQPLMTLIFGRLTTSFTNYAVIANQISQGGLTPETSAALQAAKDDLKTQSGHNALYLMAIGIGMFLATWLYMFIWNVTGELNSKRIRERYLAAVLRQEIAYFDDLGAGEVATRIQTDCHLVQEGTSEKVALVFQYAGTFVCGFVLAFVRSPRLAGALVSILPVIMLCGGIMMTAMAKYGTAALDHIAKAGSLAEEVIGSIRTVQAFGKEKILGDKFADHIEQSKIVGRKGSIFEGFGLSIMFFVIYAAYALAFFYGGILVSNGQADSGIVINVFMSILIGSFSMAMLAPELAAVTKARGAAAKLFATIDRVPAIDSASEEGFKPDGLRGEISFENVKFHYPSRPSIPILKGFTTTFEAGKTFALVGASGSGKSTVVSLIERFYDPVSGVVKLDGRDIRSLNLNWLRQQIGLVSQEPTLFGTTVRGNVEHGLIGSRYENASLEEKFELVKKACVDANAHNFIMKLPQGYDTMVGERGMLLSGGQKQRVAIARAIVSDPRILLLDEATSALDTQSEGIVQDALDKASRGRTTITIAHRLSTIRDADRIYVMGGGEVLEQGSHNDLLANENGPYAQLVNNQKLAQEAAAEALQVDDDIEDPDDAVFIGGSSPMQEKDKQLHRAVTGRSLASIAMDDIQAKRAEEVAGEDKIPSSFGLYARLLRMNSADKFIYIIAFIAAICAGMVYPSLAILFGKALSDFEIQDPAELRHALSRSALWYFITALAAAFVIFFQSAGFSRAGWDLNGVLRKKLFTATLRHDIEWFDEERNSTGAVTSNLADQPQKVQGLFGPTLGTVVQSCATLIGGCIIGLCYGPLLALIGIACIPILVSGGYIRLKVVVLKDQRMKKLHAASAHLASEAAGAVKTVASLTREKDVRRIYSEALKAPMKLNFRTSIKSQCLFAASQGLTFCIIALVFYIGALWIIDAKYSTASFYTVLNSIVFASIQAGNVFTFVPDASKANSSAASIFRSIDNEPAINAESNEGKVLDHKHVVGHVRIEGVHFRYPTRPGVRVLRNLTIDVPAGTYVALVGPSGCGKSTTIQMLERFYDPLAGRVTLDGIDIKELNLASYRSQISLVSQEPTLYAGTIRFNILLGANKPIEEVTQDEIDAACKDANIYDFIVSLPDGFDTEVGGKGSQLSGGQKQRIAIARALIRNPKVLLLDEATSALDSQSEKVVQEALDKAAKGRTTIAIAHRLSSIQHSDRIYYFSEGRVAEHGTHQELLAKKGGYYELVQMQNLSRQ